Question 1

Does Linden Advisors own SAREPTA THERAPEUTICS stock?

Accepted Answer

No. Linden Advisors exited its SAREPTA THERAPEUTICS position in Q4 2025. Its Q3 2025 13F listed 40,510,000 shares worth $35.6M.

Question 2

How many shares of SAREPTA THERAPEUTICS does Linden Advisors own?

Accepted Answer

None since Q4 2025, when Linden Advisors exited the position. Its Q3 2025 13F listed 40,510,000 shares worth $35.6M.

Question 3

What is Linden Advisors' SAREPTA THERAPEUTICS position worth?

Accepted Answer

Linden Advisors' SAREPTA THERAPEUTICS position was worth $35.6M in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Linden Advisors buying or selling SAREPTA THERAPEUTICS?

Accepted Answer

In Q4 2025, Linden Advisors exited its entire SAREPTA THERAPEUTICS position.

Question 5

When did Linden Advisors first buy SAREPTA THERAPEUTICS?

Accepted Answer

Linden Advisors already held SAREPTA THERAPEUTICS in its Q3 2023 13F, the earliest on record, and listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2025-Q3	Decreased	40.5M	-85.8%	$35.6M	0.2%	—	0
2025-Q2	Increased	284.5M	+85.8%	$208.8M	1.3%	—	75
2025-Q1	Increased	153.1M	+69.0%	$142.5M	1.0%	—	63
2024-Q4	Decreased	90.6M	-11.7%	$99.9M	0.8%	—	0
2024-Q3	Decreased	102.6M	-36.5%	$116.7M	1.0%	—	0

SASAREPTA THERAPEUTICS INC